Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;12(15):e031618.
doi: 10.1161/JAHA.123.031618. Epub 2023 Jul 25.

Introducing AHA's New President: Joseph C. Wu, MD, PhD, FAHA

Bridget M Kuehn

Introducing AHA's New President: Joseph C. Wu, MD, PhD, FAHA

Bridget M Kuehn. J Am Heart Assoc. 2023 Aug.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Dr. Joseph Wu arrived at Stanford University in 2004.
His academic journey has led him to cutting‐edge research on induced pluripotent stem cells—blood or skin cells that have been reprogrammed so they can become any type of human cell. Reproduced with permission from American Heart Association.
Figure 2
Figure 2. In his office, Dr Joseph Wu's coffee mug displays the mantra he teaches his mentees: “Work hard/Work smart/Work together.”
The mug was a gift from one of those mentees. Reproduced with permission from American Heart Association.
See this image and copyright information in PMC

References

    1. Ince S, Wu JC. Joseph C. Wu: envisioning personalized medicine and clinical trials in a dish. Circ Res. 2015;117:599–602. doi: 10.1161/CIRCRESAHA.115.307390 - DOI - PubMed
    1. Wnorowski A, Sharma A, Chen H, Wu H, Shao NY, Sayed N, Liu C, Countryman S, Stodieck LS, Rubins KH, et al. Effects of spaceflight on human induced pluripotent stem cell‐derived cardiomyocyte structure and function. Stem Cell Rep. 2019;13:960–969. doi: 10.1016/j.stemcr.2019.10.006 - DOI - PMC - PubMed
    1. Sun N, Yazawa M, Liu J, Han L, Sanchez‐Freire V, Abilez OJ, Navarrete EG, Hu S, Wang L, Lee A, et al. Patient‐specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Sci Transl Med. 2012;4:130ra47. doi: 10.1126/scitranslmed.3003552 - DOI - PMC - PubMed
    1. Lan F, Lee AS, Liang P, Sanchez‐Freire V, Nguyen PK, Wang L, Han L, Yen M, Wang Y, Sun N, et al. Abnormal calcium handling properties underlie familial hypertrophic cardiomyopathy pathology in patient‐specific induced pluripotent stem cells. Cell Stem Cell. 2013;12:101–113. doi: 10.1016/j.stem.2012.10.010 - DOI - PMC - PubMed
    1. Garg P, Oikonomopoulos A, Chen H, Li Y, Lam CK, Sallam K, Perez M, Lux RL, Sanguinetti MC, Wu JC. Genome editing of induced pluripotent stem cells to decipher cardiac channelopathy variant. J Am Coll Cardiol. 2018;72:62–75. doi: 10.1016/j.jacc.2018.04.041 - DOI - PMC - PubMed

LinkOut - more resources